AbstractBackgroundEarly resuscitation after trauma-hemorrhagic shock (HS) with plasma rather than crystalloid may ameliorate systemic endothelial cell (EC) injury and dysfunction (endotheliopathy of trauma [EOT]). We postulated that endothelial lined microfluidic networks would be a useful platform to study the endothelial cell activation/injury under flow conditions to mimic HS. We then used the microfluidic system to further characterize the protective effects and optimal timing of plasma infusion on the development of “EOT” in our model.MethodsHuman umbilical vein endothelial cells (HUVEC) were added to microfluidic flow channels and after overnight perfusion the cells were subsequently treated with epinephrine (epi) and exposed to hypoxia reoxygenation (HR). Media alone or 5% human plasma was perfused either immediately following treatment (early plasma) or after a 3 hr. delay (late plasma). Glycocalyx injury was indexed by fluorescent microscopy and shedding of syndecan-1 and hyaluronic acid (HLA). Endothelial markers of activation/injury were also measured and included soluble thrombomodulin (sTM), tissue plasminogen activator (tPA), plasminogen activator inhibitor (PAI-1) and angiopoietin 1 and 2 (Ang-1 and 2). Sheddase activity was indexed by ADAM metallopeptidase domain 17 (ADAM-17).ResultsEndothelial cell and glycocalyx barrier function studied using microfluidic devices are a more realistic model of the glycocalyx endothelial vascular barrier than studies performed on endothelial cells using static (no flow) conditions. Conditions that mimic the internal mileau following hemorrhagic shock result in glycocalyx degradation and an inflammatory prothrombotic response by the endothelium. “Early” use of plasma in the microfluidic channel perfusate mitigated against these effects. Later perfusion with plasma had no protective effect.ConclusionA temporal effect to plasma administration was noted in our biomimetic model of the endothelial vascular barrier following shock. This suggests a protective role to “early” plasma administration in the severely injured patient. Background Early resuscitation after trauma-hemorrhagic shock (HS) with plasma rather than crystalloid may ameliorate systemic endothelial cell (EC) injury and dysfunction (endotheliopathy of trauma [EOT]). We postulated that endothelial lined microfluidic networks would be a useful platform to study the endothelial cell activation/injury under flow conditions to mimic HS. We then used the microfluidic system to further characterize the protective effects and optimal timing of plasma infusion on the development of “EOT” in our model. Methods Human umbilical vein endothelial cells (HUVEC) were added to microfluidic flow channels and after overnight perfusion the cells were subsequently treated with epinephrine (epi) and exposed to hypoxia reoxygenation (HR). Media alone or 5% human plasma was perfused either immediately following treatment (early plasma) or after a 3 hr. delay (late plasma). Glycocalyx injury was indexed by fluorescent microscopy and shedding of syndecan-1 and hyaluronic acid (HLA). Endothelial markers of activation/injury were also measured and included soluble thrombomodulin (sTM), tissue plasminogen activator (tPA), plasminogen activator inhibitor (PAI-1) and angiopoietin 1 and 2 (Ang-1 and 2). Sheddase activity was indexed by ADAM metallopeptidase domain 17 (ADAM-17). Results Endothelial cell and glycocalyx barrier function studied using microfluidic devices are a more realistic model of the glycocalyx endothelial vascular barrier than studies performed on endothelial cells using static (no flow) conditions. Conditions that mimic the internal mileau following hemorrhagic shock result in glycocalyx degradation and an inflammatory prothrombotic response by the endothelium. “Early” use of plasma in the microfluidic channel perfusate mitigated against these effects. Later perfusion with plasma had no protective effect. Conclusion A temporal effect to plasma administration was noted in our biomimetic model of the endothelial vascular barrier following shock. This suggests a protective role to “early” plasma administration in the severely injured patient. Correspondence: Lawrence N. Diebel MD, Michael and Marian Ilitch Department of Surgery, 6C University Health Center, 4201 Saint Antoine, Detroit, MI 48201, Phone: 313-577-5314, Fax: 313-577-5310, Email: ldiebel@med.wayne.edu Conflicts of interest to disclose: None This study was presented at the 75th annual meeting of the AAST, September 13-16, 2017, in Baltimore, MD. © 2017 Lippincott Williams & Wilkins, Inc.
from Emergency Medicine via xlomafota13 on Inoreader http://ift.tt/2BUaWa9
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Abstract Background Although a head and neck cancer prognosis does not have a promising long-term prognosis, approximately 50% will surv...
-
Champion EMS, based in Longview, TX is a non-Profit, 501(c)3 organization and we are seeking highly skilled Paramedics. Champion EMS provide...
-
Abstract Objective We examined the association between parent and child fruit and vegetable (F&V) intake, physical activity (PA), and...
-
Abstract Hydroxypropyl acrylate-N-diethyl-perfluorooctane sulfonamide (HAF), a novel surface active cationic fluorinated monomer, is desig...
-
Abstract Purpose The aim of the study was to identify the incidence of new sexual dysfunction reported by the patient in surgical treatmen...
-
Abstract To recognize audiovisual speech, listeners evaluate and combine information obtained from the auditory and visual modalities. Lis...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου